---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-085762"
form_type: "8-K"
ticker: "FBRX"
cik: "0001419041"
company_name: "Forte Biosciences, Inc."
filed_at: "2025-04-18T23:59:59+00:00"
generated_at: "2026-05-23T10:56:45.838375+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Forte Biosciences sets annual meeting for May 29, 2025; proposals due April 28

## Summary
- Annual meeting scheduled for May 29, 2025, more than 30 days before the 2024 anniversary.
- Stockholder proposals for proxy inclusion must be received by April 28, 2025.
- Director nominations and other proposals (non-14a-8) due no later than April 28, 2025.
- Universal proxy rule compliance notices for soliciting support of non-company nominees due April 28, 2025.
- Prior deadlines for stockholder submissions are no longer applicable due to the revised meeting date.

## SEC filing metadata
- accession: 0001193125-25-085762
- form_type: 8-K
- ticker: FBRX
- cik: 0001419041
- company_name: Forte Biosciences, Inc.
- filed_at: 2025-04-18T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1419041/000119312525085762/0001193125-25-085762-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1419041/000119312525085762/d206139d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-085762
- JSON: https://secwatch.observer/filing/0001193125-25-085762.json
- Plain text: https://secwatch.observer/filing/0001193125-25-085762.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.